Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples